Latest Us Market News

Page 14 of 79
Tetratherix Limited has raised approximately $5 million to fast-track its Tutelix prostate spacer into pivotal clinical trials across Australia and the US, aiming to improve radiation therapy for prostate cancer patients.
Ada Torres
Ada Torres
10 Mar 2026
Cyclopharm Limited has responded to ASX queries clarifying the material significance of its Technegas® contract with the US National Institutes of Health, while confirming robust progress in expanding its US footprint.
Ada Torres
Ada Torres
9 Mar 2026
New Frontier Minerals has confirmed significant high-grade tungsten mineralisation at its Harts Range Project in the Northern Territory, complementing its rare earth focus and capitalising on a soaring tungsten market. Meanwhile, its Pomme Rare Earth Project in Quebec advances with promising metallurgical testing underway.
Maxwell Dee
Maxwell Dee
6 Mar 2026
LTR Pharma has finalised recruitment for its Phase II clinical trial of SPONTAN, a rapid-acting intranasal spray for erectile dysfunction, with initial results expected in the second quarter of 2026.
Ada Torres
Ada Torres
5 Mar 2026
Peak Processing Limited has renewed and expanded its manufacturing agreement with Electric Brands, securing an expected annual production of approximately 1.4 million Sweet Justice cannabis beverage units. This deal reinforces Peak’s position in North America’s regulated cannabis beverage market and supports growth in Canada and the US.
Victor Sage
Victor Sage
3 Mar 2026
Lindian Resources has executed a binding agreement to acquire full ownership of a rare earths processing facility in Kazakhstan, marking a strategic shift from concentrate production to higher-value Mixed Rare Earth Carbonate (MREC) output by late 2026.
Maxwell Dee
Maxwell Dee
3 Mar 2026
PainChek Limited reported a half-year loss of AUD 4.7 million but achieved a major regulatory milestone with FDA clearance for its Adult App, unlocking significant US market opportunities. The company also completed a share consolidation and raised capital to support growth.
Ada Torres
Ada Torres
27 Feb 2026
Thrive Tribe Technologies reported a $1.8 million half-year loss, driven by a major software impairment and ongoing operational challenges, while raising over $1.5 million in fresh capital to support its evolving business model.
Sophie Babbage
Sophie Babbage
27 Feb 2026
Lumos Diagnostics reported a 74% increase in its half-year loss to US$4.88 million, despite strong progress with its FebriDx diagnostic test and a landmark US distribution agreement. The company awaits a critical FDA decision that could unlock significant revenue growth.
Ada Torres
Ada Torres
27 Feb 2026
HighCom Limited has revealed a sharp downturn in its half-year results, with revenue plunging 59% and a $6.8 million loss after tax, driven by US government shutdown impacts. The company is banking on new lightweight XTclave® armour products to fuel a recovery in the second half of FY26.
Victor Sage
Victor Sage
27 Feb 2026
Bubs Australia has delivered a robust first half for FY26, powered by a 48% revenue surge in the US, prompting an upgrade to its full-year earnings guidance.
Victor Sage
Victor Sage
27 Feb 2026
BetMakers Technology Group Ltd reported an 11.4% rise in half-year revenue to $46.1 million alongside a dramatic 80% reduction in losses, setting the stage for accelerated global growth and a strategic US market push.
Sophie Babbage
Sophie Babbage
27 Feb 2026